Danaher Corporation $DHR Stock: TD Waterhouse Canada Inc. Increases Stake

TD Waterhouse Canada Inc. raised its holdings in Danaher Corporation (NYSE:DHR) by 120.8% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 136,920 shares of the conglomerate’s stock after buying an additional 74,905 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in Danaher were worth $30,335,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Main Street Group LTD acquired a new position in shares of Danaher during the first quarter worth approximately $25,000. N.E.W. Advisory Services LLC acquired a new stake in shares of Danaher in the second quarter worth $25,000. Marquette Asset Management LLC grew its stake in shares of Danaher by 192.1% in the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 73 shares during the last quarter. Evolution Wealth Management Inc. grew its stake in shares of Danaher by 208.0% in the first quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 104 shares during the last quarter. Finally, Field & Main Bank bought a new position in Danaher during the second quarter worth $29,000. 79.05% of the stock is owned by institutional investors.

Danaher Trading Down 1.1%

Danaher stock opened at $228.87 on Friday. The business has a 50 day moving average price of $214.04 and a two-hundred day moving average price of $195.97. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The stock has a market cap of $160.89 billion, a price-to-earnings ratio of 40.65, a price-to-earnings-growth ratio of 2.88 and a beta of 0.76. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter last year, the firm earned $0.77 EPS. As a group, equities analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is 28.42%.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on DHR shares. Barclays upped their target price on shares of Danaher from $230.00 to $255.00 and gave the company an “overweight” rating in a research note on Wednesday, October 7th. Stifel Nicolaus reduced their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Morgan Stanley raised their price target on shares of Danaher from $220.00 to $240.00 and gave the stock an “overweight” rating in a research report on Monday, October 12th. Weiss Ratings upgraded shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. Finally, Royal Bank Of Canada boosted their price objective on shares of Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a report on Monday, October 5th. Two research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $235.41.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.